Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD36-positive B-lymphoblasts Predict Poor Outcome in Children With B-lymphoblastic Leukemia.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society - 1 Jun 2017

Newton Joanna G, Horan John T, Newman Scott, Rossi Michael R, Ketterling Rhett P, Park Sunita I

Abstract excerpt

Objective We observed that pediatric patients with B lymphoblastic leukemia which expressed CD36 at diagnosis seemed to have worse outcome than patients whose blasts did not. Here, we describe the patient, disease characteristics, pathological, molecular, and genetic features and outcomes of patients with CD36+ B-LL compared to patients with CD36- B-LL. Methods We retrospectively reviewed all flow cytometry...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to CD36 Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Follow-Up Studies

Share to Infant

Share to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Share to Prognosis

Share to Survival Analysis

Source

Identifiers

PMID: 28521628
DOI: 10.1177/1093526616688753

Genes

EFS
ABL2
NRAS
PDGFRB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD36-positive B-lymphoblasts Predict Poor Outcome in Children With B-lymphoblastic Leukemia.PMID 28521628Read ↗

Improving leukemic CD34 <sup>+</sup> /CD38 <sup>−</sup> blasts characterization with single-cell transcriptome sequencingSemantic proximity Read ↗

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaSemantic proximity Read ↗

Integrated Genomic Analysis Identifies ANKRD36 Gene as a Novel and Common Biomarker of Disease Progression in Chronic Myeloid LeukemiaSemantic proximity Read ↗

Comparison of the Transcriptomic Signatures in Pediatric and Adult CMLSemantic proximity Read ↗

Integrated Genomic Analysis Identifies ANKRD36 Gene as a Novel and Common Biomarker of Disease Progression in Chronic Myeloid LeukemiaSemantic proximity Read ↗

Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome PredictionSemantic proximity Read ↗

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia.Semantic proximity Read ↗

High proportion of CD34+/CD38-cells is positively correlated with poor prognosis in newly diagnosed childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

The role of CD56 in predicting the prognosis of AML in childrenSemantic proximity Read ↗

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemiaSemantic proximity Read ↗

Investigations on Clinical Validation of mutated ANKRD36 as a Novel Molecular Biomarker for Monitoring Early Progression and Timely Therapeutic Interventions in Blast Crisis CMLSemantic proximity Read ↗

Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.